^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             34    10631001 10631002 10631003    
                           11601006 11601007 13031001    
                           13031004 13581001 13581014    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661004 17661006 19691001    
                           19731001 19731002 19731006    
                           19831001 19831005 19831008    
                           19901003                      
      AVISITN         1    4                             
      SSNRISN         2    1 2                           
      trtn            3    1 2 3                         
 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters             1
              Columns in X                     14
              Columns in Z                      0
              Subjects                         34
              Max Obs per Subject               1


                    Number of Observations

          Number of Observations Read              34
          Number of Observations Used              34
          Number of Observations Not Used           0


 
 
 
 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       243.36782958                
          1              1       243.36782958      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           144.33


 
 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             -2 Res Log Likelihood           243.4
             AIC (Smaller is Better)         245.4
             AICC (Smaller is Better)        245.5
             BIC (Smaller is Better)         246.9


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   0          0.00          1.0000


 
 
 
 
 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      29      15.51    0.0005
      trtn                  2      29       0.07    0.9312
      AVISITN               0                             
      AVISITN*trtn          0                             
      BASE*AVISITN          0                             
      SSNRISN               1      29       0.37    0.5468
      AVISITN*SSNRISN       0                             


                      Least Squares Means
 
                Analysis                       Standard
 Effect         Visit (N)    trtn   Estimate      Error     DF

 AVISITN*trtn            4   1      -17.5594     4.2971     29
 AVISITN*trtn            4   2      -15.6149     3.8312     29
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis                       Standard
 Effect         Visit (N)    trtn   Estimate      Error     DF

 AVISITN*trtn            4   3      -16.6936     3.9573     29

                      Least Squares Means
 
                Analysis
 Effect         Visit (N)    trtn   t Value   Pr > |t|    Alpha

 AVISITN*trtn            4   1        -4.09     0.0003     0.05
 AVISITN*trtn            4   2        -4.08     0.0003     0.05
 AVISITN*trtn            4   3        -4.22     0.0002     0.05

 
 
 
 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                   Analysis
    Effect         Visit (N)    trtn      Lower       Upper

    AVISITN*trtn            4   1      -26.3479     -8.7708
    AVISITN*trtn            4   2      -23.4507     -7.7792
    AVISITN*trtn            4   3      -24.7872     -8.6001


              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  1              4  2       -1.9444
  AVISITN*trtn           4  1              4  3       -0.8657
  AVISITN*trtn           4  2              4  3        1.0787

 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           4  1              4  2        5.2253
  AVISITN*trtn           4  1              4  3        5.4014
  AVISITN*trtn           4  2              4  3        4.8837

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           4  1              4  2        29    -0.37
AVISITN*trtn           4  1              4  3        29    -0.16
AVISITN*trtn           4  2              4  3        29     0.22

 
 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           4  1              4  2        0.7125
  AVISITN*trtn           4  1              4  3        0.8738
  AVISITN*trtn           4  2              4  3        0.8267

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           4  1              4  2        0.05
   AVISITN*trtn           4  1              4  3        0.05
   AVISITN*trtn           4  2              4  3        0.05

 
 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.5.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Secondary E
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           4  1              4  2      -12.6313
  AVISITN*trtn           4  1              4  3      -11.9129
  AVISITN*trtn           4  2              4  3       -8.9096

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           4  1              4  2        8.7425
  AVISITN*trtn           4  1              4  3       10.1814
  AVISITN*trtn           4  2              4  3       11.0670
 
 
 
 
 
^S={}CAPS: Clinician Administered PTSD Scale; CAPS-5 total score
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: The CAPS-5 total score is the sum of the 20 item-scor
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: TheLS means, SEs, LS Mean Diff, 95% CI and p-value fo
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
